Cardiology

  • Aspirin for primary prevention of atherosclerotic cardiovascular events
    Aldo L. Schenone, MD and A. Michael Lincoff, MD
    Cleveland Clinic Journal of Medicine May 2020, 87 (5) 300-311; DOI: https://doi.org/10.3949/ccjm.87a.19045

    A more limited role for aspirin as primary prevention in patients at intermediate risk, with diabetes, and the elderly.

  • A practical approach to the cholesterol guidelines and ASCVD prevention
    Leslie Cho, MD
    Cleveland Clinic Journal of Medicine May 2020, 87 (5 suppl 1) 15-20; DOI: https://doi.org/10.3949/ccjm.87.s1.02
  • New treatments for peripheral artery disease
    John Bartholomew, MD and G. Jay Bishop, MD
    Cleveland Clinic Journal of Medicine May 2020, 87 (5 suppl 1) 21-25; DOI: https://doi.org/10.3949/ccjm.87.s1.03
  • Functional tricuspid regurgitation: Feasibility of transcatheter interventions
    Vinayak Nagaraja, MD, Divyanshu Mohananey, MD, Jose Navia, MD, Serge C. Harb, MD, Rhonda Miyasaka, MD, Amar Krishnaswamy, MD and Samir Kapadia, MD
    Cleveland Clinic Journal of Medicine May 2020, 87 (5 suppl 1) 4-14; DOI: https://doi.org/10.3949/ccjm.87.s1.01
  • Infective endocarditis: Don’t forget the ICE
    Faris G. Araj, MD and Michael Luna, MD
    Cleveland Clinic Journal of Medicine April 2020, 87 (4) 191; DOI: https://doi.org/10.3949/ccjm.87c.04001

    A recent article did not mention intracardiac echocardiography.

  • In reply: Infective endocarditis: Don’t forget the ICE
    Nkemdilim Mgbojikwe, MD, Steven R. Jones, MD, Thorsten M. Leucker, MD, PhD and Daniel J. Brotman, MD
    Cleveland Clinic Journal of Medicine April 2020, 87 (4) 192; DOI: https://doi.org/10.3949/ccjm.87c.04002

    Echocardiography relies on finding an anatomic abnormality, whereas 18FDG-PET is a functional examination.

  • ACC/AHA lipid guidelines: Personalized care to prevent cardiovascular disease
    Cara Reiter-Brennan, Albert D. Osei, MD, MPH, S. M. Iftekhar Uddin, MBBS, MSPH, Olusola A. Orimoloye, MD, MPH, Olufunmilayo H. Obisesan, MD, MPH, Mohammadhassan Mirbolouk, MD, Michael J. Blaha, MD, MPH and Omar Dzaye, MD, PhD
    Cleveland Clinic Journal of Medicine April 2020, 87 (4) 231-239; DOI: https://doi.org/10.3949/ccjm.87a.19078

    Risk assessment, drugs, patient subgroups, value of therapy, personalized plans, and shared decision-making.

  • Mitral valve prolapse and sudden cardiac death: A perspective on risk-stratification
    Aaron A. H. Smith, MD and Omer J. Iqbal, MD, FHRS
    Cleveland Clinic Journal of Medicine March 2020, 87 (3) 136-138; DOI: https://doi.org/10.3949/ccjm.87a.19096

    Mitral valve prolapse is common, but sudden cardiac death is rare. How can we stratify risk?

  • Pharmacogenomics: An evolving clinical tool for precision medicine
    Jennifer K. Hockings, PharmD, PhD, Amy L. Pasternak, PharmD, Angelika L. Erwin, MD, PhD, Neil T. Mason, MBA, Charis Eng, MD, PhD and J. Kevin Hicks, PharmD, PhD
    Cleveland Clinic Journal of Medicine February 2020, 87 (2) 91-99; DOI: https://doi.org/10.3949/ccjm.87a.19073

    More than 90% of patients are thought to carry at least 1 genetic variant that should prompt a change in dosing or medication.

  • Are we all clear? Unintended shocks to caregivers during cardiopulmonary resuscitation
    David R. Lowery, MD, FASA, Maj, MC, USA, Daniel Cantillon, MD, FACC, FHRS and Donn Marciniak, MD
    Cleveland Clinic Journal of Medicine January 2020, 87 (1) 16-18; DOI: https://doi.org/10.3949/ccjm.87a.19022

    Defibrillators are designed to affect electrical activity in the patient’s heart. Caregivers, be careful!

Pages